Citron Research, led by Andrew Left, is doubling down on its quantum computing pick, noting that it has successfully transitioned from being a conceptual science project to a commercial reality.

This Is No Longer ‘A Science Project’

On Monday, in a post on X, Left reiterated his bullish stance on Infleqtion (NASDAQ:CCCX), a neutral atom quantum technology company, citing its collaboration with French aeronautics giant, Safran SA, for GPS-independent timing solutions for “mission-critical systems.”

Left said Infleqtion, which went public via a SPAC merger earlier this year, is “no longer a science project,” signaling a shift from experimental development to what he views as a commercially viable phase. “This is real.”

See Also: What’s Going On With Quantum Computing Stocks Today?

Citron highlighted the stark contrast between Infleqtion and Rigetti Computing Inc. (NASDAQ:RGTI), another quantum computing company, which “can't even make stage 2 with DARPA,” which refers to the benchmarks set by the U.S. Government’s Defense Advanced Research Projects Agency.

Yet, Rigetti trades at a market capitalization of $7.84 billion, while Infleqtion trades at just over $720 million. Citron said that it expects the market capitalization of ...